Having trouble viewing this e-mail? CLICK HERE
Pharm Tech
March 2019
Volume 43, No. 3
VIEW ONLINE ARCHIVE SUBSCRIBE FORWARD Twitter LinkedIn

| COVER STORY |

Embracing the Digital Factory for Bio/Pharma Manufacturing

Jennifer Markarian

New technologies in the digital factory enhance quality, efficiency, and flexibility.
read more


| EXCIPIENTS |

Strategic Screening for Solubility Solutions

Cynthia A. Challener

Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.
read more

PharmTech March Issue
Read the issue online Subscribe or renew your Pharm Tech subscription

| FORMULATION |

Rising to the Challenge of Biologic Drug Formulation

Felicity Thomas

As biologics continue to push boundaries, the industry needs to take a holistic approach to formulation to ensure success.
read more


|MANUFACTURING: SOLID DOSAGE|

Assuring the Safe Handling of Potent APIs, Intermediates, and Solid-Dosage Drugs

Michael Avraam

Containment valves and smart monitoring can keep employees safe and improve manufacturing efficiency when handling potent APIs, intermediates, and solid-dosage drugs.
read more


| MANUFACTURING: REFURBISHED EQUIPMENT |

Tablet Press Refurbishment: Why and How?

Matt Bundenthal

Identify the warning signs and follow best practices for refurbishment to improve tablet press yields.
read more


| PEER-REVIEWED RESEARCH |

Real-Time Measurement of Coating Film Thickness

Matthias Wolfgang, Patrick Wahl, Stephan Sacher, Elen Gartshein, Johannes G. Khinast

This article summarizes results of a study that looked at optical coherence tomography as a way to monitor pharmaceutical spray coating processes in-line for tablets and pellets.
read more


| ANALYTICS |

Key Considerations in Stability Testing

Felicity Thomas

Harmonization of best practices and regulatory requirements will enable developers to find the best stability testing approach.
read more


| QUALITY |

Reinterpreting Benchmarks for Innovative Therapies

Agnes Shanley

While allogeneic therapies can use existing regulatory and quality frameworks, autologous treatments will require pharma's adoption of true just-in-time and right-first-time concepts, says consultant James Blackwell.
read more


| FROM THE EDITOR |

Caught in a Conundrum

Rita C. Peters

Do patients get what they pay for when they demand cheaper drugs?
read more


| US REGULATORY WATCH |

Cell and Gene Therapies Gain Streamlined FDA Oversight

Jill Wechsler

FDA expects more than 200 investigational new drug applications for cell and gene therapies by 2020, causing the agency to strengthen its regulatory program.
read more


| OUTSOURCING OUTLOOK |

CMOs Leading the Way on Single-Use Systems Adoption

Ilene Roizman, Eric Langer

Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.
read more


| ASK THE EXPERT |

Is Simplification Aiding Data Integrity Compliance?

Siegfried Schmitt

Simplification is crucial to maintain data integrity, according to Siegfried Schmitt, PhD, vice-president, technical at PAREXEL Consulting.
read more


UPCOMING WEBCASTS

Formulation Development for Scalability: Manufacturing Strategies for Bioavailability-Enhancing Technologies
Wednesday, April 3, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now


Capsugel® Vcaps® Plus: The New Standard in HPMC Capsules
Thursday, March 28, 2019 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Register Now


Ensuring Integrity of Drug Formulation from Development to QC
Wednesday, March 27, 2019 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Register Now


ON DEMAND WEBCASTS

Benefits of Using High-Functionality Excipients in a Continuous Process
On Demand
Learn more


Top 4 Quality Trends for 2019
Pharma Quality Outlook Survey

On Demand
Learn more


| Events |

Pittcon 2019

March 17–21, 2019

DCAT Week '19

March 18–21, 2019

INTERPHEX

April 2–4, 2019


more events

Contribute an article | contact the editors | contact sales | subscribe | advertise